Fingerprint
Dive into the research topics of 'Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically